Title |
Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya
|
---|---|
Published in |
BMC Infectious Diseases, June 2012
|
DOI | 10.1186/1471-2334-12-143 |
Pubmed ID | |
Authors |
Elizabeth O Onyango, George Ayodo, Carren A Watsierah, Tom Were, Wilson Okumu, Samuel B Anyona, Evans Raballah, John M Okoth, Sussy Gumo, George O Orinda, Collins Ouma |
Abstract |
Over the years, reports implicate improper anti-malarial use as a major contributor of morbidity and mortality amongst millions of residents in malaria endemic areas, Kenya included. However, there are limited reports on improper use of Artemisinin-based Combination Therapy (ACT) which is a first-line drug in the treatment of malaria in Kenya. Knowing this is important for ensured sustainable cure rates and also protection against the emergence of resistant malarial parasites. We therefore investigated ACT adherence level, factors associated with non-adherence and accessibility in households (n = 297) in rural location of Southeast Alego location in Siaya County in western Kenya. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Indonesia | 1 | <1% |
United Kingdom | 1 | <1% |
Unknown | 121 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 29 | 24% |
Researcher | 14 | 11% |
Student > Ph. D. Student | 9 | 7% |
Student > Doctoral Student | 8 | 7% |
Student > Bachelor | 8 | 7% |
Other | 26 | 21% |
Unknown | 29 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 36 | 29% |
Social Sciences | 12 | 10% |
Agricultural and Biological Sciences | 10 | 8% |
Biochemistry, Genetics and Molecular Biology | 7 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 5% |
Other | 22 | 18% |
Unknown | 30 | 24% |